Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002339 · ClinicalTrials.gov registry record · Phase 3
A Study of Fluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems
A Phase 3 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 100
- Enrollment target
NCT00002339 is a Phase 3 study that has completed, run by Pfizer. The registered enrollment target is 100 participants.
The verdict
NCT00002339, a Phase 3 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 100 participants
- Enrollment target
Study Summary
To determine the safety, toleration, and efficacy of fluconazole oral suspension in the treatment of esophageal candidiasis in immunocompromised patients, including those with AIDS.
Interventions
- DRUG Fluconazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002339
The ClinicalTrials.gov registry entry for NCT00002339 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fluconazole is the first listed.
NCT00002339 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002339 about?
NCT00002339 is a clinical study titled "A Study of Fluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems". To determine the safety, toleration, and efficacy of fluconazole oral suspension in the treatment of esophageal candidiasis in immunocompromised patients, including those with AIDS.
What is the current status of trial NCT00002339?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 100 participants.
What interventions are being tested in trial NCT00002339?
The interventions under investigation include: Fluconazole (DRUG).
Who is sponsoring clinical trial NCT00002339?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.